Acro Biomedical Co Stock Today
| ACBM Stock | USD 0 0.00 0.00% |
Performance0 of 100
| Odds Of DistressOver 65
|
ACRO Biomedical is selling at 0.001 as of the 2nd of December 2024; that is No Change since the beginning of the trading day. The stock's lowest day price was 0.001. ACRO Biomedical has more than 65 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. Equity ratings for ACRO Biomedical Co are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 5th of June 2024 and ending today, the 2nd of December 2024. Click here to learn more.
Acro Biomedical Co., Ltd. engages in developing and marketing of nutritional products. Acro Biomedical Co., Ltd. was incorporated in 2014 and is based in Fishers, Indiana. Acro Biomedical operates under Biotechnology classification in the United States and is traded on OTC Exchange.. The company has 60.04 M outstanding shares. More on ACRO Biomedical Co
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
ACRO Pink Sheet Highlights
| CEO | PaoChi Chu |
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
ACRO Biomedical Co [ACBM] is a Pink Sheet which is traded between brokers over the counter. The company currently falls under 'Small-Cap' category with a current market capitalization of 209.55 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate ACRO Biomedical's market, we take the total number of its shares issued and multiply it by ACRO Biomedical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. ACRO Biomedical conducts business under Healthcare sector and is part of Biotechnology industry. The entity has 60.04 M outstanding shares.
ACRO Biomedical Co currently holds about 12.11 K in cash with 299.33 K of positive cash flow from operations.
Check ACRO Biomedical Probability Of Bankruptcy
Ownership AllocationACRO Biomedical holds a total of 60.04 Million outstanding shares. ACRO Biomedical retains considerable amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company secures, if the real value of the entity is less than the current market value, you may not be able to make money on it.
Check ACRO Ownership Details
ACRO Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in ACRO Biomedical without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Pattern Recognition Now
Pattern RecognitionUse different Pattern Recognition models to time the market across multiple global exchanges |
| All Next | Launch Module |
ACRO Biomedical Corporate Management
| ChengHsiang Kao | Managing Director | Profile | |
| YunYuan Chu | Managing Director | Profile | |
| AnTao Fong | Managing Director | Profile | |
| CheLi Lin | VP Technical | Profile |
Other Information on Investing in ACRO Pink Sheet
ACRO Biomedical financial ratios help investors to determine whether ACRO Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ACRO with respect to the benefits of owning ACRO Biomedical security.